(Q72684979)
Statements
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017) (English)
J W Mulder
D A Cooper
L Mathiesen
E Sandström
N Clumeck
J M Gatell
M French
F Gray